| Annual Financials | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 42 | 40 | 43 | 48 | 47 | 48 |
| Expenses | 32 | 32 | 34 | 40 | 39 | 40 |
| EBITDA | 9 | 7 | 9 | 9 | 8 | 9 |
| Operating Profit % | 22 % | 19 % | 20 % | 17 % | 17 % | 17 % |
| Depreciation | 0 | 1 | 1 | 2 | 3 | 3 |
| Interest | 0 | 0 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 9 | 7 | 7 | 6 | 6 | 6 |
| Tax | 2 | 2 | 2 | 2 | 1 | 1 |
| Net Profit | 7 | 5 | 5 | 4 | 5 | 4 |
| EPS in ₹ | 6.91 | 4.90 | 5.36 | 4.03 | 3.09 | 3.10 |
Shanmuga Hospital
Shanmuga Hospital
41.59
0.00
(0.00%)
Market Cap
56.60 Cr
PE Ratio
13.33
Volume
2,000.00
Day High - Low
41.59 - 41.59
52W High-Low
56.76 - 34.00
Key Fundamentals
Market Cap
56.60 Cr
EPS
3.09
PE Ratio
13.33
PB Ratio
1.33
Book Value
31.22
EBITDA
8.29
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
10.60
Debt to Equity
0.29
Actual
Company News
View All News
Shanmuga Hospital Limited schedules its 6th AGM for September 18, 2026. Key agenda items include a ₹11 crore authorized capital increase, new object clauses for medical education and IT, and an ESOP scheme.
Shanmuga Hospital Limited reported stable FY26 net profit of ₹421.1 lakh and revenue of ₹4,743.6 lakh. The company fully utilized IPO proceeds for capital expenditure, including the operationalization of the Da Vinci Xi robotic surgical system.
Shanmuga Hospital Q1FY27: Profit rises 4% YoY
Aug 11, 2026
Aug 11, 2026Shanmuga Hospital Ltd reports Q1FY27 net profit of ₹98.65 lakh, up 3.9% YoY, with revenue rising 3.4% to ₹1,186.71 lakh. Board also approves ESOP and capital hike.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,838.50 | #1 1,27,084.07 | 58.29 | #1 25,420.10 | 15.58 | #1 2,003 | 38.41 | 52.01 | |
1,014.10 | 98,696.65 | 67.33 | 8,536.10 | 18.82 | 1,442 | 4.87 | 42.15 | |
926.75 | 69,965.75 | 64.61 | 9,178.50 | 16.93 | 1,064 | 2.25 | 49.47 | |
1,472.20 | 39,582.71 | 73.64 | 4,508.90 | 19.56 | 554 | -1.07 | 59.64 | |
1,932.10 | 39,484.55 | 47.65 | 7,996.30 | #1 43.43 | 811 | 5.39 | 57.01 | |
748.40 | 38,776.18 | 181.54 | 4,643.22 | 8.32 | 384 | -68.70 | 32.24 | |
771.00 | 32,382.50 | 166.27 | 3,930.80 | 28.16 | 242 | -56.00 | 41.30 | |
507.80 | 16,096.40 | 85.05 | 2,080.08 | 18.39 | 168 | #1 44.36 | 53.97 | |
1,442.80 | 14,652.96 | 50.30 | 1,746.90 | 11.49 | 282 | 16.17 | 42.53 | |
290.55 | 12,549.75 | #1 42.21 | 1,679.36 | 17.77 | 272 | 35.27 | 58.57 |
Growth Rate
Revenue Growth
-1.37 %
Net Income Growth
15.48 %
Cash Flow Change
-231.94 %
ROE
-65.39 %
ROCE
-60.25 %
EBITDA Margin (Avg.)
-2.10 %
Yearly Financial Results
Order Value Trend
FY 2026-271 Orders
Central Government Health Sche...
0.00%Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 11 | 23 | 34 | 53 | 53 |
| Fixed Assets | 2 | 10 | 16 | 22 | 40 |
| Current Assets | 8 | 13 | 14 | 30 | 13 |
| Capital Work in Progress | 0 | 0 | 4 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 8 | 13 | 14 | 30 | 0 |
| Total Equity & Liabilities | 11 | 23 | 34 | 53 | 53 |
| Current Liabilities | 4 | 7 | 13 | 9 | 6 |
| Non Current Liabilities | 0 | 4 | 4 | 4 | 5 |
| Total Equity | 7 | 12 | 17 | 40 | 43 |
| Reserve & Surplus | 7 | 12 | 7 | 26 | 29 |
| Share Capital | 0 | 0 | 10 | 14 | 14 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 2 | -1 | -1 |
| Investing Activities | -2 | -8 | -12 | -5 |
| Operating Activities | 2 | 3 | 10 | -13 |
| Financing Activities | 0 | 7 | 1 | 16 |
Share Holding
| % Holding | Dec 2024 | Feb 2025 | Mar 2025 | Sept 2025 | Mar 2026 |
| Promoter | 71.95 % | 71.95 % | 72.11 % | 72.06 % | 72.06 % |
| FIIs | 0.00 % | 0.00 % | 0.19 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 25.92 % | 25.92 % | 24.48 % | 24.76 % | 24.33 % |
| Others | 2.13 % | 2.13 % | 3.22 % | 3.19 % | 3.61 % |
| No of Share Holders | 1,772 | 9 | 1,449 | 1,156 | 1,008 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 Sept 2026 |  Annual General Meeting | NA | 18 Sept 2026 | 44.50 | 41.59 |
| 28 May 2025 |  Quarterly Result Announcement | NA | 28 May 2025 | 38.10 | 38.50 |
| 19 Sept 2025 | Annual General Meeting | NA | 19 Sept 2025 | 45.65 | 48.00 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 42.50 | 42.65 |
| 11 May 2026 | Quarterly Result Announcement | NA | 11 May 2026 | 41.00 | 42.00 |
| 11 Aug 2026 | Quarterly Result Announcement | NA | 11 Aug 2026 | 43.50 | 44.50 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoReg. 34 (1) Annual Report.5 days ago
5 days agoNotice Of The 06Th Annual General Meeting Of Shanmuga Hospital Limited Is Scheduled To Be Held On Friday The 18Th September 2026 At 02.30 P.M. Through Video Conference Or Other Audio Visual Means.5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationAug 11, 2026
Aug 11, 2026 Increase In The Authorized Share Capital Of The Company.Aug 11, 2026
Aug 11, 2026Unaudited Financial Results For The Quarter Ended June 302026Aug 11, 2026
Aug 11, 2026Board Meeting Outcome for Un-Audited Financial Results And Fixing The Date Of AGM And Employees Stock Option PlanAug 11, 2026
Aug 11, 2026Board Meeting Intimation for Approving The Unaudited Financial Results For The Quarter Ended June 30 2026 And To Consider And Approve Employee Stock Option Plan.Aug 03, 2026
Aug 03, 2026Testing Phase Of "Shanmuga 360" Mobile ApplicationJul 13, 2026
Jul 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Jul 07, 2026CGHS Empanelment-Execution Of MOAJul 06, 2026
Jul 06, 2026Closure of Trading WindowJun 24, 2026
Jun 24, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 04, 2026
Jun 04, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 11, 2026
May 11, 2026Audited Financial Results For The Half Year And Year Ended March 31 2026.May 11, 2026
May 11, 2026Board Meeting Outcome for Approval Of Audited Financial Results For The Half Year And Year Ended 31St March 2026.May 11, 2026
May 11, 2026Board Meeting Intimation for Approving The Audited Financial Results For The Quarter And Year Ended March 31 2026.Apr 30, 2026
Apr 30, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2026
Apr 29, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Apr 09, 2026Closure of Trading WindowMar 23, 2026
Mar 23, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 21, 2026
Mar 21, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 13, 2026
Mar 13, 2026Intimation Regarding Commissioning And Operationalisation Of Litho Evo Laser MachineJan 09, 2026
Jan 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Jan 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 28, 2025
Nov 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 28, 2025
Nov 28, 2025Statement On Deviation Or VariationNov 12, 2025
Nov 12, 2025Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for To Approve The Unaudited Financial Results For The Half Year Ended On 30Th September 2025Nov 04, 2025
Nov 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Oct 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 08, 2025
Oct 08, 2025Shanmuga Hospital Limited Honoured At Times Healthcare Achievers - Tamil Nadu 2025 For Contribution To HealthcareSep 30, 2025
Sep 30, 2025Closure Of Shanmuga ClinicsSep 30, 2025
Sep 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 25, 2025
Sep 25, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 22, 2025
Sep 22, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Sep 16, 2025Intimation Of Book Closure For The Purpose Of 05Th Annual General Meeting Of The Company.Sep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Aug 26, 2025Reg. 34 (1) Annual Report.Aug 25, 2025
Aug 25, 2025Notice Of The 05Th Annual General Meeting Of Shanmuga Hospital Limited Is Scheduled To Be Held On Friday The 19Th September 2025 At 03.00 P.M. Through Video Conference Or Other Audio Visual Means.Aug 25, 2025
Aug 25, 2025Intimation Regarding Commissioning And Operationalization Of PH Impedance & Manometry SystemAug 16, 2025
Aug 16, 2025Board Meeting Outcome for Outcome Of The Board Meeting
Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Aug 11, 2025Technical Indicators
RSI(14)
Neutral 46.08
ATR(14)
Less Volatile 2.17
STOCH(9,6)
Neutral 33.38
STOCH RSI(14)
Oversold 4.26
MACD(12,26)
Bearish -0.63
ADX(14)
Weak Trend 23.94
UO(9)
Bearish 45.87
ROC(12)
Downtrend And Accelerating -8.59
WillR(14)
Oversold -83.26
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
